KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term InvestmentsNon-Current AssetsOther Accumulated ExpensesOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShort-term InvestmentsTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Silicon Laboratories (SLAB) Common Equity (2016 - 2026)

Historic Common Equity for Silicon Laboratories (SLAB) over the last 18 years, with Q1 2026 value amounting to $1.1 billion.

  • Silicon Laboratories' Common Equity rose 133.3% to $1.1 billion in Q1 2026 from the same period last year, while for Jan 2026 it was $1.1 billion, marking a year-over-year increase of 133.3%. This contributed to the annual value of $1.1 billion for FY2026, which is 133.3% up from last year.
  • As of Q1 2026, Silicon Laboratories' Common Equity stood at $1.1 billion, which was up 133.3% from $1.1 billion recorded in Q4 2025.
  • Over the past 5 years, Silicon Laboratories' Common Equity peaked at $2.2 billion during Q1 2022, and registered a low of $1.1 billion during Q3 2025.
  • Moreover, its 5-year median value for Common Equity was $1.2 billion (2023), whereas its average is $1.3 billion.
  • Data for Silicon Laboratories' Common Equity shows a peak YoY increase of 8439.31% (in 2022) and a maximum YoY decrease of 4139.39% (in 2022) over the last 5 years.
  • Silicon Laboratories' Common Equity (Quarter) stood at $1.4 billion in 2022, then fell by 13.97% to $1.2 billion in 2023, then decreased by 10.64% to $1.1 billion in 2024, then decreased by 0.86% to $1.1 billion in 2025, then rose by 2.21% to $1.1 billion in 2026.
  • Its Common Equity was $1.1 billion in Q1 2026, compared to $1.1 billion in Q4 2025 and $1.1 billion in Q3 2025.